The global Nuclear Receptor ROR Gamma market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Nuclear Receptor ROR Gamma volume and value at global level, regional level and company level. From a global perspective, this report represents overall Nuclear Receptor ROR Gamma market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Nuclear Receptor ROR Gamma in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Nuclear Receptor ROR Gamma manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Genfit SA
GlaxoSmithKline Plc
Aurigene Discovery Technologies Ltd
Beijing Hanmi Pharmaceutical Co Ltd
Biogen Inc
AbbVie Inc
Advinus Therapeutics Ltd
Brickell Biotech Inc
Pfizer Inc
Phenex Pharmaceuticals AG
Reata Pharmaceuticals Inc
Bristol-Myers Squibb Company
Celgene Corp
Eli Lilly and Company
Glenmark Pharmaceuticals Ltd
Lead Pharma Holding BV
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
BBI-6000
GRC-39815Action
R&D Progress
GSK-2981278
IMU-366
INV-17
Others
Segment by Application
Chronic Obstructive Pulmonary Disease
Asthma
Axial Spondyloarthritis
Breast Cancer
Others
Table of Contents
Executive Summary
1 Industry Overview of Nuclear Receptor ROR Gamma
1.1 Definition of Nuclear Receptor ROR Gamma
1.2 Nuclear Receptor ROR Gamma Segment by Type
1.2.1 Global Nuclear Receptor ROR Gamma Production Growth Rate Comparison by Types (2014-2025)
1.2.2 BBI-6000
1.2.3 GRC-39815Action
1.2.4 R&D Progress
1.2.5 GSK-2981278
1.2.6 IMU-366
1.2.7 INV-17
1.2.8 Others
1.3 Nuclear Receptor ROR Gamma Segment by Applications
1.3.1 Global Nuclear Receptor ROR Gamma Consumption Comparison by Applications (2014-2025)
1.3.2 Chronic Obstructive Pulmonary Disease
1.3.3 Asthma
1.3.4 Axial Spondyloarthritis
1.3.5 Breast Cancer
1.3.6 Others
1.4 Global Nuclear Receptor ROR Gamma Overall Market
1.4.1 Global Nuclear Receptor ROR Gamma Revenue (2014-2025)
1.4.2 Global Nuclear Receptor ROR Gamma Production (2014-2025)
1.4.3 North America Nuclear Receptor ROR Gamma Status and Prospect (2014-2025)
1.4.4 Europe Nuclear Receptor ROR Gamma Status and Prospect (2014-2025)
1.4.5 China Nuclear Receptor ROR Gamma Status and Prospect (2014-2025)
1.4.6 Japan Nuclear Receptor ROR Gamma Status and Prospect (2014-2025)
1.4.7 Southeast Asia Nuclear Receptor ROR Gamma Status and Prospect (2014-2025)
1.4.8 India Nuclear Receptor ROR Gamma Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Nuclear Receptor ROR Gamma
2.3 Manufacturing Process Analysis of Nuclear Receptor ROR Gamma
2.4 Industry Chain Structure of Nuclear Receptor ROR Gamma
3 Development and Manufacturing Plants Analysis of Nuclear Receptor ROR Gamma
3.1 Capacity and Commercial Production Date
3.2 Global Nuclear Receptor ROR Gamma Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Nuclear Receptor ROR Gamma
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Nuclear Receptor ROR Gamma Production and Capacity Analysis
Summary: Get latest Market Research Reports on Nuclear Receptor ROR Gamma . Industry analysis & Market Report on Nuclear Receptor ROR Gamma is a syndicated market report, published as Global Nuclear Receptor ROR Gamma Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Nuclear Receptor ROR Gamma market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.